A New Canadian Plant-Based COVID-19 Vaccine Is Looking For 30,000 People For Testing

You can apply to participate in the clinical trial.
Contributor

On Tuesday, March 16, Quebec-based Medicago announced that they will be moving into Phase 3 of clinical testing of their plant-based COVID-19 vaccine candidate. 

Medicago's COVID-19 vaccine candidate is "plant-derived," and, as it moves to late-stage clinical testing, 30,000 people will be able to volunteer for the trials. 

Editor's Choice: Here Are All The Essential Workers Who Can Get Vaccines First In Ontario

"The trial will take place in 10 countries pending regulatory approvals, starting with Canada and the United States," said a press release

They'll be testing a range of "males and females from ethnically and racially diverse populations." 

You must be over the age of 18 to apply and must not have received a COVID-19 vaccine or diagnosis. 

Health Canada has a robust website with all the latest information on the vaccines and can answer any questions you may have. Click here for more information.

  • Britanny Burr was a Staff Writer at Narcity Canada, who drove growth within Narcity's Western coverage and readership. Having lived between her hometown, Canmore, Alberta and Calgary, Montreal, Vancouver, and NYC over the past 10 years, she is obsessed with finding the best local hot spots. She holds a B.A. in English and has over six years of professional writing experience as Head Writer and Editor for YUL.Buzz in Montreal, and Creative Copywriter at JAKT in NYC. News by day, poetry by night — the written word is Britanny's nearest and dearest.

Ontario's weather forecast calls for up to 40 cm as snow squalls bring blizzard conditions

Widespread snowfall is also forecast in Toronto and the GTA this week.